SALL4 and embryonal carcinoma: A SALL4-positive expression was seen in almost all non-trophoblastic GCT (seminoma, embryonal carcinoma (EC) and YST) and in germ cell neoplasia in situ, and in nearly 80% of choriocarcinomas and 60% of immature teratoma [6].